Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against

Aksam J Merched1, Lawrence Chan

  • 1Department of Molecular, Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. amerched@bcm.tmc.edu

Circulation
|December 15, 2004
PubMed
Abstract

Insights

Loss of p21 protects against atherosclerosis. Absence of p21 in bone marrow cells reduces inflammation and enhances macrophage function, revealing a novel anti-inflammatory mechanism.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Immunology

Background:

  • The tumor suppressor p53 plays a role in preventing atherosclerosis.
  • p53 targets p21, a cyclin-dependent kinase inhibitor crucial for cell cycle regulation and macrophage differentiation.
  • p21's role in atherosclerosis has been debated, with some studies suggesting a protective function.

Purpose of the Study:

  • To investigate the effect of p21 inactivation on atherosclerosis development in apolipoprotein E-deficient (apoE-/-) mice.
  • To elucidate the mechanisms underlying p21's influence on macrophage function and vascular inflammation.

Main Methods:

  • Atherosclerosis development was studied in p21-/-/apoE-/- mice and compared to p21+/+/apoE-/- controls.
  • Gene expression profiles of macrophages were analyzed using real-time polymerase chain reaction.
  • Macrophage phagocytic activity was assessed using latex microspheres and apoptotic cells.

Main Results:

  • Absence of p21 protected against atherosclerosis, leading to more stable atherosclerotic lesions.
  • p21 deficiency resulted in increased apoptosis and reduced expression of inflammatory markers in lesions.
  • p21-deficient macrophages showed reduced pro-inflammatory gene expression and enhanced phagocytic capacity.

Conclusions:

  • Loss of p21 confers protection against atherosclerosis in apoE-/- mice.
  • p21 significantly influences macrophage function and inflammation.
  • The study reveals a novel pro-atherogenic role for p21 in macrophages.